Skip to main content
MITKMitek Systems, Inc.Sell6.6·$15.31
MITK · Why this verdict

Why Mitek Systems (MITK) is rated SELL

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

VerdictSELL
Overall score6.6/10
ConfidenceMEDIUM
MacroCRISIS
TrendMatrix Research · core thesis

Engine thesis — one sentence

Mitek is a high-quality, cheaply valued software company (forward P/E 13.3x, 4-for-4 beats) with 25.6% upside to the analyst target, held back by weak momentum, product concentration and an earnings report due in 18 days.

Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.

Thesis pillars

Mitek is high quality: a Piotroski F-Score of 9/9, 225% FCF-to-net-income conversion, a wide moat and a Rule of 40 reading of 44 (pass).

→Stable
Quality breakdown
Expectation
Piotroski score stays at 8 or above and FCF conversion stays above 100%.

CounterROE (3.1/10) and ROA (3.7/10) are low, so returns on capital are modest despite strong cash conversion.

Concentration risk from reliance on mobile imaging technology and software products is a flagged high-severity risk.

↓Deteriorating
Bear case
Expectation
Revenue from the core mobile imaging products continues to grow without disruption.

CounterA single product line dependency exposes revenue to competition or technology change, and the technology sector modifier is -1.5.

Mitek beat EPS estimates in 4 of 4 recent quarters with an average surprise of 26.6%, latest $0.34 vs $0.28.

↓Deteriorating
Earnings
Expectation
Earnings keep beating estimates, including the report due December 10, 2026.

CounterSmall absolute EPS figures inflate surprise percentages, and a miss on the upcoming report would break the streak that the stock's earnings catalyst depends on.

Valuation is attractive at forward P/E 13.3x and PEG 0.06, with price $15.31 about 25.6% below the $19.23 analyst target.

↑Improving
Valuation breakdown
Expectation
Price moves toward the analyst target as earnings growth continues.

CounterA $0.7B market cap and a 93% implied volatility make the stock volatile, and cheap multiples on small-cap software often persist.

Momentum is weak at 2.7/10 with falling on-balance volume, though price is below a 200-day average that is still rising (+7.2%/30d).

↓Deteriorating
Momentum breakdown
Expectation
Momentum recovers above 4.5 as price reclaims the 200-day average.

CounterVolume distribution suggests selling pressure, and the pullback could become a confirmed downtrend ahead of earnings.

Per-dimension breakdown

Value

7.7/10data confidence 100%
ComponentSub-score
P/E4.0
P/S7.9
EV/EBITDA4.1
Fwd P/E8.6
PEG10.0
Analyst target9.0
  • ▸Forward P/E: 13.3x
  • ▸PEG: 0.06
  • ▸Attractively valued

Quality

7.4/10data confidence 100%
ComponentSub-score
ROE3.1
ROA3.7
Gross margin10.0
Op margin7.2
Net margin5.7
Current ratio9.2
FCF quality10.0
Moat7.9
Rule of 407.5
Piotroski F10.0
  • ▸Excellent cash conversion: 225% FCF/NI
  • ▸Wide economic moat
  • ▸Rule of 40: 44 (pass)
  • ▸Strong Piotroski F-Score: 9/9

Growth

8.6/10data confidence 67%
ComponentSub-score
Rev growth7.1
EPS growth10.0

Momentum

2.7/10data confidence 100%
ComponentSub-score
RSI3.5
MACD0.0
OBV1.0
MA position2.2
Volume7.0
  • ▸Volume distribution (falling OBV)
  • ▸Below 200-MA but MA still rising (+7.2%/30d) — pullback in uptrend, not confirmed weakness

Sentiment

6.7/10data confidence 100%
ComponentSub-score
LLM sentiment6.0
Analyst rating5.0
Price target9.5
  • ▸Analyst upside: 48%

Insider

6.2/10data confidence 75%
ComponentSub-score
materiality5.0
holder change6.7
notable moves7.0
  • ▸No net insider activity — $0 (0.000% of mkt cap)

Peer rank

5.5/10data confidence 80%
ComponentSub-score
value rank4.8
quality rank5.1
growth rank6.5

Technical

7.5/10data confidence 100%
ComponentSub-score
bollinger10.0
support resistance9.4
52w position4.5
gap6.0

Risk (lower is worse)

3.9/10data confidence 100%
ComponentSub-score
short interest5.2
days to cover2.3
volatility0.0
put call3.9
implied vol0.0
max pain risk3.0
beta7.4
debt equity9.1
  • ▸High IV: 93%
  • ▸Above max pain $8
  • ▸Concentration risks: 1 HIGH (10-K Item 1A — sized via position_sizing, validated via buy_confidence)

Catalyst

7.0/10data confidence 100%
ComponentSub-score
erm5.0
earnings history10.0
earnings timing5.0
surprise avg10.0
news activity5.0
  • ▸Perfect beat streak: 4Q

How the verdict was assembled

Engine trigger

Multiple concerning factors. Consider reducing position.

Engine technical detail
verdict_path: L4:PATH_F_SELL
Passed (6)
  • ASYMMETRY:1.7>=1.5
  • INSIDER:OK
  • 8K:CLEAN
  • EARNINGS_PROXIMITY:18d clear
  • SEMI_CYCLE_PEAK:CLEAR
  • MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
  • MOMENTUM:2.7<4.5
Warning (0)

none

Reward-to-Risk
1.71
Upside
+25.6%
Downside
15.0%
Sizing output
AVOID

Setup— — No clear chart pattern; technical signals are mixed

EdgeCatalyst-Driven — Earnings in 18d with 4/4 beat streak

SuitabilityAggressive — MCap $0.7B<$5B

Investment implication

The F-path SELL output reflects an overall score of 4.3 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Growth at 8.6) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( MOMENTUM:2.7<4.5) reinforce the read. Current asymmetry R:R is 1.71 — supplementary context, not the trigger for this path.

The strongest dimensions are Growth at 8.6, Value at 7.7, and Technical at 7.5; the weakest are Momentum at 2.7, Risk (lower is worse) at 3.9, and Peer rank at 5.5. The V9 engine flagged 1 failed gate, producing an asymmetric reward-to-risk of 1.71 and an engine sizing output of AVOID.

What would invalidate the thesis

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1Consistent Earnings Beat Streak

    Trip ifEPS surprise stays below 0% for 2 consecutive quarters.

  • P2High Quality Wide Moat

    Trip ifPiotroski F-Score falls below 6 from current 9.

  • P3Attractive Valuation Upside

    Trip ifForward P/E rises above 20x from current 13.3x.

  • P4Weak Momentum Pullback

    Trip ifPrice falls below the $14.58 stop-loss level.

  • P5Product Concentration Risk

    Trip ifRevenue growth falls below 5% YoY from current mid-range growth score of 7.1/10.

Engine reasoning is mechanically derived from pipeline gate outputs. See decision view.

Home › Stocks › MITK › Why this verdict